11q23 rearrangement and duplication of MLLT1-MLL gene fusion in therapy-related acute myeloid leukemia

Leukemia and Lymphoma

Volumn 53, Issue 10, 2012, Pages 2066-2068

  Chin, Loi Khim ^a,b   Cheah, Chan Y ^c   Michael, Patricia M ^b   MacKinnon, Ruth N ^b   Campbell, Lynda J ^b,d  

^a HOSPITAL KUALA LUMPUR   (Malaysia)

^b ST VINCENT S HOSPITAL   (Australia)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD15 ANTIGEN; CD33 ANTIGEN; CD64 ANTIGEN; CYTARABINE; HEMOGLOBIN; HLA DR ANTIGEN; IDARUBICIN; MYELOPEROXIDASE; STEM CELL FACTOR RECEPTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; BONE MARROW CELL; CASE REPORT; CHROMOSOME 11Q; CHROMOSOME DUPLICATION; CHROMOSOME REARRANGEMENT; DRUG TOLERABILITY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FUSION; HEMOGLOBIN BLOOD LEVEL; HETEROCHROMATIN; HUMAN; IMMUNOPHENOTYPING; KARYOTYPE; LETTER; MEDICAL HISTORY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT DURATION;

AZATHIOPRINE; CHROMOSOME BANDING; CHROMOSOMES, HUMAN, PAIR 11; CYCLOSPORINE; FEMALE; GENE DUPLICATION; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOID, ACUTE; MYELOID-LYMPHOID LEUKEMIA PROTEIN; NEOPLASM PROTEINS; NUCLEAR PROTEINS; ONCOGENE PROTEINS, FUSION; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC; YOUNG ADULT;

EID: 84865802083     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2012.666663     Document Type: Letter

References (14)

1. Thirman MJ, Gill HJ, Burnett RC, et al. Rearrangement of the MLLgene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. NEngl JMed 1993;329:909-914.
2. Vardiman JW, Arber DA, Brunning RD, et al. Therapy related myeloid neoplasms. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHOclassification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008. pp 127-129.
3. Seong D, Kantarjian H, Ro J. Hypermetaphase fluorescence in situ hybridization for quantitative monitoring of Philadelphia chromosomepositive cells in patients with chronic myelogenous leukemia during treatment. Blood 1995;86:2343-2349.
4. Shaffer LG, Slovak ML, Campbell LJ, editors. ISCN2009: an international system for human cytogenetic nomenclature. Basel: S. Karger; 2009.
5. Felix CA. Secondary leukemias induced by topoisomerase-targeted drugs. Biochim Biophys Acta 1998;1400:233-255.
6. Meyer C, Kowarz E, Hofmann J, et al. New insights to the MLLrecombinome of acute leukemias. Leukemia 2009;23:1490-1499.
7. Daser A, Rabbitts TH. The versatile mixed lineage leukaemia gene MLLand its many associations in leukaemogenesis. Semin Cancer Biol 2005;15:175-188.
8. Zach O, Haas O, Klingebiel T, et al. Spliced MLLfusions: a novel mechanism to generate functional chimeric MLL-MLLT1 transcripts in t(11;19)(q23;p13.3) leukemia. Leukemia 2007;21:588-590.
9. Rubnitz J, Behm F, Downing J. 11q23 rearrangements in acute leukemia. Leukemia 1996;10:74-82.
10. Schoch C, Schnittger S, Klaus M, et al. AMLwith 11q23/MLLabnormalities as defined by the WHOclassification: incidence, partner chromosomes, FABsubtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AMLcases. Blood 2003;102:2395-2402.
11. Blum W, Mr ó zek K, Ruppert AS, et al. Adult de novo acute myeloid leukemia with t(6;11)(q27;q23): results from Cancer and Leukemia Group BStudy 8461 and review of the literature. Cancer 2004;101: 1420-1427.
12. Pui C-H, Chessells JM, Camitta B, et al. Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements. Leukemia 2003;17:700-706.
13. Grimwade D, Hills RK, Moorman AV, et al. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood 2010;116:354-365.
14. Debatisse M, Coquelle A, Toledo F, et al. Gene amplification mechanisms: the role of fragile sites. Recent Results Cancer Res 1998;154:216-226.